6101 - 6150 of 6422 Results
Title
Year
-
OPENTitle: Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 93Issue #:Start Page: 143.e1End Page: 143.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.03.021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7302975Citation Count: 18
- Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief Report2025OPENTitle: Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief ReportJournal Name: Journal of Sleep ResearchPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/jsr.70108Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jsr.70108Citation Count: 0
-
OPENTitle: Using Wearable Sensors and Machine Learning to Automatically Detect Freezing of Gait during a FOG-Provoking TestJournal Name: SensorsPublisher: MDPI AGVol: 20Issue #: 16Start Page: 4474End Page: 4474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s20164474Best OA location URL: https://www.mdpi.com/1424-8220/20/16/4474/pdf?version=1624544211Citation Count: 56
- Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?2020OPENTitle: Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?Journal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 192Issue #:Start Page: 105728End Page: 105728Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2020.105728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7183413Citation Count: 2
-
OPENTitle: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteomeJournal Name: PROTEOMICSPublisher: WileyVol: 15Issue #: 2-3Start Page: 500End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201400171Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4598062Citation Count: 54
-
OPENTitle: A novel class of negative allosteric modulators of NMDA receptor functionJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 25Issue #: 23Start Page: 5583End Page: 5588Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2015.10.046Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7971076Citation Count: 15
-
OPENTitle: Multiple system atrophy and apolipoprotein EJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 647End Page: 650Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27297Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5889322Citation Count: 19
-
OPENTitle: Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s modelsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 607End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1873-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6123262Citation Count: 132
-
OPENTitle: Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00907-2Best OA location URL: https://www.nature.com/articles/s41531-025-00907-2.pdfCitation Count: 0
-
OPENTitle: Sex Disparities in Autonomic Symptom Treatment in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 718End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12997Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12997Citation Count: 6
- Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment2020OPENTitle: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00362-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00362-yCitation Count: 79
-
OPENTitle: Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharideJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 115End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.08.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5734673Citation Count: 63
-
OPENTitle: Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 80Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlaa160Best OA location URL: https://academic.oup.com/jnen/article-pdf/80/3/240/36335359/nlaa160.pdfCitation Count: 20
-
OPENTitle: Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 123Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2019.09.015Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/226efa6a-7701-420c-935c-2c284c758e52Citation Count: 16
-
OPENTitle: Predictors of time to initiation of symptomatic therapy in early Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 7Start Page: 482End Page: 494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.317Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.317Citation Count: 27
-
OPENTitle: Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2086Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2086Citation Count: 6
-
OPENTitle: Predictive model of spread of Parkinson's pathology using network diffusionJournal Name: NeuroImagePublisher: Elsevier BVVol: 192Issue #:Start Page: 178End Page: 194Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2019.03.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7180066Citation Count: 73
-
OPENTitle: Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease ResearchJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00524Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00524/pdfCitation Count: 35
-
OPENTitle: CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 3Start Page: 271End Page: 276Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.12.027Best OA location URL: http://doi.org/10.1016/j.parkreldis.2014.12.027Citation Count: 91
-
OPENTitle: Forecasts for the Attainment of Major Research Milestones in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1047End Page: 1055Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201933Best OA location URL: https://doi.org/10.17863/cam.52302Citation Count: 4
-
OPENTitle: Striatal shape alteration as a staging biomarker for Parkinson’s DiseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 27Issue #:Start Page: 102272End Page: 102272Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2020.102272Best OA location URL: https://doi.org/10.1016/j.nicl.2020.102272Citation Count: 8
-
OPENTitle: Structure of the second phosphoubiquitin–binding site in parkinJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 7Start Page: 102114End Page: 102114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114Best OA location URL: http://www.jbc.org/article/S0021925822005555/pdfCitation Count: 21
-
OPENTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 887End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30359-8Best OA location URL: http://www.thelancet.com/article/S1474442220303598/pdfCitation Count: 2
-
OPENTitle: Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in ratsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-85293-4Best OA location URL: https://www.nature.com/articles/s41598-021-85293-4.pdfCitation Count: 14
-
OPENTitle: Differences in the Presentation and Progression of Parkinson's Disease by SexJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 106End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28312Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28312Citation Count: 79
-
OPENTitle: Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 34Issue #:Start Page: 15End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.10.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5222688Citation Count: 36
-
OPENTitle: Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-74195-6Best OA location URL: https://www.nature.com/articles/s41598-020-74195-6.pdfCitation Count: 36
-
OPENTitle: LRRK2 activity does not dramatically alter α-synuclein pathology in primary neuronsJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-018-0550-0Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-018-0550-0Citation Count: 37
-
OPENTitle: The cerebral tremor circuit in a patient with Holmes tremorJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 8Start Page: 1453End Page: 1458Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51143Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51143Citation Count: 12
-
OPENTitle: The Parkinson's Disease Genome‐Wide Association Study Locus BrowserJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2056End Page: 2067Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28197Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2021-00254%22Citation Count: 92
-
OPENTitle: Functional selectivity induced by mGlu4 receptor positive allosteric modulation and concomitant activation of Gq coupled receptorsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 122End Page: 132Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3412075Citation Count: 13
- Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression2015OPENTitle: Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progressionJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 37Issue #:Start Page: 209.e1End Page: 209.e7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.09.014Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2015.09.014Citation Count: 103
-
OPENTitle: Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremorJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 201Issue #:Start Page: 106691End Page: 106691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2024.106691Best OA location URL: https://doi.org/10.1016/j.nbd.2024.106691Citation Count: 0
-
OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 52
-
OPENTitle: Digital health technology for Parkinson's disease with comprehensive monitoring and artificial intelligence-enabled haptic biofeedback for bulbar dysfunctionJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251329354Best OA location URL: https://doi.org/10.1177/1877718x251329354Citation Count: 0
-
OPENTitle: High-resolution local field potentials measured with deep brain stimulation arraysJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 15Issue #: 4Start Page: 046019End Page: 046019Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1088/1741-2552/aabdf5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6021212Citation Count: 16
-
OPENTitle: Differential involvement of Ras‐GRF1 and Ras‐GRF2 in L‐DOPA‐induced dyskinesiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 6Start Page: 662End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.202Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.202Citation Count: 20
-
OPENTitle: Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated MonkeysJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 11Start Page: 1543End Page: 1551Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00186Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00186Citation Count: 9
-
OPENTitle: Cortical structural involvement and cognitive dysfunction in early Parkinson's diseaseJournal Name: NMR in BiomedicinePublisher: WileyVol: 31Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/nbm.3900Citation Count: 8
-
OPENTitle: The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and humanJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 11Start Page: 1861End Page: 1883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20180248Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/11/1861/691623/bcj-2018-0248.pdfCitation Count: 199
-
OPENTitle: Novel recruitment strategy to enrich forLRRK2mutation carriersJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 3Issue #: 5Start Page: 404End Page: 412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mgg3.151Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.151Citation Count: 18
-
OPENTitle: Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesiaJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 6Start Page: 2246End Page: 2255Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10411-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11197155Citation Count: 12
-
OPENTitle: Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 CasesJournal Name: Sleep DisordersPublisher: WileyVol: 2011Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2011/468952Best OA location URL: https://downloads.hindawi.com/journals/sd/2011/468952.pdfCitation Count: 9
-
OPENTitle: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1Journal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 4Start Page: 561End Page: 576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12483Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12483Citation Count: 63
-
OPENTitle: Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 2Start Page: 106End Page: 121Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51482Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51482Citation Count: 35
-
OPENTitle: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0679-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0679-5Citation Count: 45
-
OPENTitle: Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaa004Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/1/fcaa004/33639616/fcaa004.pdfCitation Count: 10
-
OPENTitle: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy BiomarkerJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 22Start Page: 16445End Page: 16445Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms242216445Best OA location URL: https://www.mdpi.com/1422-0067/24/22/16445/pdf?version=1700208971Citation Count: 4
-
OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Citation Count: 42
-
OPENTitle: Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreJournal Name: European Journal of NeurosciencePublisher: WileyVol: 45Issue #: 1Start Page: 175End Page: 191Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ejn.13476Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13476Citation Count: 24